Is Genmab A/S (GNMSF) a Buy, Sell, or Hold?
OTC : GNMSF
Genmab A/S — Institutional Ownership
$295 USD
$0 (0.0%)
- Volume
- 101
- Average Volume
- 1.68K
- Market Capitalization
- $18.11B
- P/E Ratio
- 24.05
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $352.00
- Year Low
- $216.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.46
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | ORBIS INVESTMENT MANAGEMENT LTD | 3.55M | 5.50% |
| 2026-02-17 | ORBIS INVESTMENT MANAGEMENT LTD | 4.23M | 6.60% |
| 2025-12-30 | Genmab A/S | - | 0.00% |
| 2025-12-30 | Genmab Holding II B.V. | - | 0.00% |
| 2025-12-19 | Genmab A/S | 71.95M | 94.80% |
| 2025-12-19 | Genmab Holding II B.V. | 71.95M | 94.80% |
| 2025-11-14 | ORBIS INVESTMENT MANAGEMENT LTD | 3.73M | 5.80% |
| 2025-04-23 | BlackRock, Inc. | 3.71M | 5.60% |
| 2023-02-06 | Wellington Management Group LLP | 4.07M | 6.18% |
| 2023-02-06 | Wellington Group Holdings LLP | 4.07M | 6.18% |
| 2023-02-06 | Wellington Investment Advisors Holdings LLP | 4.07M | 6.18% |
| 2023-02-06 | Wellington Management Company LLP | 3.73M | 5.66% |
| 2020-02-07 | Rupert H. Johnson, Jr. | 6.57M | 7.40% |
GNMSF Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $314.00 | 62.15M | $19.52B | $1.71B | $5.54B | $23.34B |
| 2024-12-31 | $1493.73 | 64.63M | $96.54B | $9.86B | $1.03B | $87.72B |
| 2023-12-31 | $2131.63 | 65.31M | $139.22B | $14.87B | $770M | $125.12B |
| 2022-12-31 | $2969.06 | 65.39M | $194.14B | $9.89B | $597M | $184.84B |
| 2021-12-31 | $2553.00 | 65.4M | $166.96B | $8.96B | $425M | $158.42B |
| 2020-12-31 | $2549.01 | 65.18M | $166.14B | $7.26B | $319M | $159.2B |
| 2019-12-31 | $1441.71 | 62.96M | $90.77B | $3.55B | $181M | $87.4B |
| 2018-12-31 | $1047.11 | 61.27M | $64.15B | $532.91M | -$ | $63.62B |
| 2017-12-31 | $1034.10 | 60.83M | $62.91B | $1.35B | -$ | $61.56B |
| 2016-12-31 | $1125.45 | 59.88M | $67.39B | $307.02M | -$ | $67.08B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $275.00 | 61.34M | $16.87B | $1.5B | $5.25B | $20.62B |
| 2026-03-31 | $265.00 | 61.38M | $16.27B | $1.52B | $5.35B | $20.1B |
| 2025-12-31 | $314.00 | 61.62M | $19.35B | $1.71B | $5.54B | $23.18B |
| 2025-09-30 | $308.00 | 61.6M | $18.97B | $1.76B | $142M | $17.35B |
| 2025-06-30 | $211.09 | 61.76M | $13.04B | $1.3B | $148.41M | $11.89B |
| 2025-03-31 | $189.80 | 63.72M | $12.1B | $1.65B | $145.36M | $10.59B |
| 2024-12-31 | $1493.73 | 63.96M | $95.53B | $9.86B | $1.03B | $86.7B |
| 2024-09-30 | $1570.90 | 63.49M | $99.74B | $6.34B | $987M | $94.38B |
| 2024-06-30 | $1767.11 | 64.44M | $113.87B | $4.33B | $1.02B | $110.56B |
| 2024-03-31 | $2053.14 | 65.3M | $134.08B | $14.67B | $1.01B | $120.42B |
| 2023-12-31 | $2131.63 | 65.33M | $139.26B | $14.87B | $770M | $125.16B |
| 2023-09-30 | $2512.57 | 65.31M | $164.09B | $14.27B | $793M | $150.61B |